Close
DCA Vantage™ Analyzer
Deliver Optimal Diabetes Care with Clinical Confidence
Drive diabetes patient compliance using the DCA Vantage Analyzer with clinically proven HbA1c1, Albumin and Creatinine tests and Albumin-to-Creatinine (A:C) ratio results. Simple enough to use in your office or clinic, and yet powerful enough to deliver lab-quality performance at the point of care.
- Only 1μL of whole blood needed for HbA1c testing
- HbA1c results in 6 minutes. Receive actionable results during the patient visit reducing follow-up time and increasing diabetes patient compliance
- Microalbumin testing allows for early detection of kidney disease – results available in 7 minutes
- No sample or reagent preparation needed allowing for simple and efficient operation
- Printed patient records and electronic transmission to LIS or electronic medical record allows for reduced transcription errors
- Trending graphs enable more comprehensive patient disease management
The analyzer leverages robust technology and delivers the proven performance of the DCA HbA1c and DCA Microalbumin/Creatinine tests highlighted in over 100 clinical articles. Provide the clinical confidence you and your patients deserve by adopting the DCA Vantage system, the analyzer used by three out of four physicians who perform HbA1c testing in their office2.
Tracking Down Diabetes, from the Australian Outback to the East Coast of the U.S
References
1. Immediate feedback of HbA1c levels improves glycemic control in Type 1 and insulin-treated Type 2 diabetic patients. Cagliero E, Levina DV, Nathan DM. Diabetes Care 1999;22:1785-9.
2. GHX Q3 FY2010 Data, HbA1c US Market Data.
3. International Expert Committee Report on the Roles of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care. 2009;32:7:1327-1334.
Text Size
|
|
